Journal of Clinical Medicine, Год журнала: 2024, Номер 13(20), С. 6079 - 6079

Опубликована: Окт. 12, 2024

Adult growth hormone deficiency (GHD) has been recognized since the late 1980s. The clinical manifestations of adult GHD are often nonspecific, and diagnosis relies on GH stimulation tests, which intricate, costly, time-consuming, may carry risk adverse effects. Diagnosis is further complicated by factors like age, sex, BMI, affect response during testing. Therefore, replacement therapy remains challenging, requiring careful individualized evaluation risks benefits. aim this review to provide an update diagnosing treating GHD, addressing current limitations challenges based recent studies.

Язык: Английский